A detailed history of Neo Ivy Capital Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 297,627 shares of ADMA stock, worth $5.26 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
297,627
Previous 48,584 512.6%
Holding current value
$5.26 Million
Previous $971,000 425.64%
% of portfolio
1.03%
Previous 0.33%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$15.62 - $22.62 $3.89 Million - $5.63 Million
249,043 Added 512.6%
297,627 $5.1 Million
Q3 2024

Nov 15, 2024

BUY
$11.21 - $20.03 $544,626 - $973,137
48,584 New
48,584 $971,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.47B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.